CAMP4 THERAPEUTICS Current Ratio vs. Target Price

CAMP Stock  USD 4.46  0.95  17.56%   
Based on CAMP4 THERAPEUTICS's profitability indicators, CAMP4 THERAPEUTICS PORATION may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess CAMP4 THERAPEUTICS's ability to earn profits and add value for shareholders.
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
1.95814777
Current Value
1.91
Quarterly Volatility
0.93663715
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, CAMP4 THERAPEUTICS's EV To Sales is relatively stable compared to the past year. As of 11/25/2024, Operating Cash Flow Sales Ratio is likely to grow to 0.05, while Price To Sales Ratio is likely to drop 1.40. As of 11/25/2024, Accumulated Other Comprehensive Income is likely to drop to about (1.8 M). In addition to that, Operating Income is likely to drop to about (9.2 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.250.3597
Way Down
Pretty Stable
For CAMP4 THERAPEUTICS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CAMP4 THERAPEUTICS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CAMP4 THERAPEUTICS PORATION utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CAMP4 THERAPEUTICS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CAMP4 THERAPEUTICS PORATION over time as well as its relative position and ranking within its peers.
  

CAMP4 THERAPEUTICS's Revenue Breakdown by Earning Segment

Check out Trending Equities.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CAMP4 THERAPEUTICS. If investors know CAMP4 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CAMP4 THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CAMP4 THERAPEUTICS is measured differently than its book value, which is the value of CAMP4 that is recorded on the company's balance sheet. Investors also form their own opinion of CAMP4 THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is CAMP4 THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CAMP4 THERAPEUTICS's market value can be influenced by many factors that don't directly affect CAMP4 THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CAMP4 THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if CAMP4 THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CAMP4 THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CAMP4 THERAPEUTICS Target Price vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining CAMP4 THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare CAMP4 THERAPEUTICS value to that of its competitors to determine the firm's financial worth.
CAMP4 THERAPEUTICS PORATION is rated below average in current ratio category among its peers. It also is rated below average in target price category among its peers fabricating about  7.62  of Target Price per Current Ratio. At this time, CAMP4 THERAPEUTICS's Current Ratio is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value CAMP4 THERAPEUTICS by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

CAMP4 Target Price vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

CAMP4 THERAPEUTICS

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
1.86 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

CAMP4 THERAPEUTICS

 = 
14.18

CAMP4 Target Price Comparison

CAMP4 THERAPEUTICS is currently under evaluation in target price category among its peers.

CAMP4 THERAPEUTICS Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in CAMP4 THERAPEUTICS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CAMP4 THERAPEUTICS will eventually generate negative long term returns. The profitability progress is the general direction of CAMP4 THERAPEUTICS's change in net profit over the period of time. It can combine multiple indicators of CAMP4 THERAPEUTICS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-1.7 M-1.8 M
Operating Income-8.7 M-9.2 M
Income Before Tax-92.7 M-88.1 M
Total Other Income Expense Net-84 M-79.8 M
Net Loss-49.3 M-51.8 M
Income Tax Expense-525 K-498.8 K
Net Interest Income2.8 MM
Interest Income2.8 MM
Net Loss-49.3 M-51.8 M
Net Loss(2.52)(2.39)
Income Quality(0.15)(0.14)
Net Income Per E B T 1.01  0.72 

CAMP4 Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on CAMP4 THERAPEUTICS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CAMP4 THERAPEUTICS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CAMP4 THERAPEUTICS's important profitability drivers and their relationship over time.

Use CAMP4 THERAPEUTICS in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

CAMP4 THERAPEUTICS Pair Trading

CAMP4 THERAPEUTICS PORATION Pair Trading Analysis

The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your CAMP4 THERAPEUTICS position

In addition to having CAMP4 THERAPEUTICS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Warren Buffett Holdings Thematic Idea Now

Warren Buffett Holdings
Warren Buffett Holdings Theme
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.